Novartis Ag (NVS) Gross Profit Growth (5y) (2014 - 2025)

Novartis Ag (NVS) Gross Profit Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 7.04%
Jun 30, 2024 2.39%
Dec 31, 2023 79.67%
Jun 30, 2023 -1.31%
Mar 31, 2023 1,155.94%
Dec 31, 2022 -314.36%
Sep 30, 2022 313.12%
Jun 30, 2022 2.53%
Mar 31, 2022 -45.76%
Dec 31, 2021 -78.51%
Sep 30, 2021 -50.00%
Jun 30, 2021 -89.47%
Mar 31, 2021 11,498.46%
Dec 31, 2020 -51.17%
Sep 30, 2020 190,212.56%
Jun 30, 2020 2,476.92%
Mar 31, 2020 1,086.73%
Jun 30, 2019 2,840.52%
Mar 31, 2019 706.62%
Dec 31, 2018 1,607.84%